Literature DB >> 18450592

Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography.

Christopher Kai-shun Leung1, Carol Yim-lui Cheung, Robert N Weinreb, Gary Lee, Dusheng Lin, Chi Pui Pang, Dennis S C Lam.   

Abstract

PURPOSE: To compare macular thickness measurements obtained from time domain optical coherence tomography (OCT) and spectral domain OCT and to evaluate their repeatability and agreement.
METHODS: Thirty-five healthy normal subjects were included. In one randomly selected eye in each subject, three serial macular measurements were obtained from a time domain OCT (Stratus OCT, Carl Zeiss Meditec, Dublin, CA) and a spectral domain OCT (3D OCT; Topcon, Tokyo, Japan) by an experienced technician in random order. Total and regional macular thicknesses obtained by the two OCTs were compared. Their agreement was examined with Bland-Altman plots. Repeatability (2.77 x within subject SD [Sw]), coefficient of variation (CVw; Sw/overall mean), and intraclass correlation coefficient (ICC) were calculated to evaluate repeatability.
RESULTS: Low variability for macular thickness measurements was found in both time domain and spectral domain OCTs. The range of the respective CVw and ICC values were 1.6% to 3.2% and 0.85 to 0.91 for Stratus OCT and 0.6% to 2.4% and 0.92 to 0.99 for 3D OCT. 3D OCT demonstrated better repeatability for total and regional macular thicknesses (all with P <or= 0.014). The foveal and total macular thicknesses measured by 3D OCT were significantly greater than those measured by Stratus OCT (both with P < 0.001). The spans of 95% limits of agreement for foveal and total macular thicknesses were 33.9 and 21.3 mum, respectively.
CONCLUSIONS: Although both time domain and spectral domain OCTs are reliable for macular thickness measurements, spectral domain OCT has better measurement repeatability compared with time domain OCT. Macular measurements obtained from the two OCT systems may not be used interchangeably.

Mesh:

Year:  2008        PMID: 18450592     DOI: 10.1167/iovs.07-1326

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  67 in total

1.  Detection of macular and circumpapillary structural loss in normal hemifield areas of glaucomatous eyes with localized visual field defects using spectral-domain optical coherence tomography.

Authors:  Jung Hwa Na; Michael S Kook; Youngrok Lee; Sung Jin Yu; Jaewan Choi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-15       Impact factor: 3.117

2.  Equations to calculate central subfield thickness on optical coherence tomography.

Authors:  Colin S H Tan; Kelvin Z Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-16       Impact factor: 3.117

3.  Quantitative analysis of the intraretinal layers and optic nerve head using ultra-high resolution optical coherence tomography.

Authors:  Yuhong Wang; Hong Jiang; Meixiao Shen; Byron L Lam; Delia Cabrera DeBuc; Yufeng Ye; Ming Li; Aizhu Tao; Yilei Shao; Jianhua Wang
Journal:  J Biomed Opt       Date:  2012-06       Impact factor: 3.170

4.  Comparison of central macular thickness between two spectral-domain optical coherence tomography in elderly non-mydriatic eyes.

Authors:  Xiao-Gang Wang; Qing Peng; Qiang Wu
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 5.  Advances in imaging of Stargardt disease.

Authors:  Y Chen; A Roorda; J L Duncan
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  [Time domain OCT versus frequency domain OCT: measuring differences of macular thickness in healthy subjects].

Authors:  S Chaber; H Helbig; Ma Gamulescu
Journal:  Ophthalmologe       Date:  2010-01       Impact factor: 1.059

7.  Comparison of retinal thickness by Fourier-domain optical coherence tomography and OCT retinal image analysis software segmentation analysis derived from Stratus optical coherence tomography images.

Authors:  Erika Tátrai; Sudarshan Ranganathan; Mária Ferencz; Delia Cabrera DeBuc; Gábor Márk Somfai
Journal:  J Biomed Opt       Date:  2011-05       Impact factor: 3.170

8.  Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness.

Authors:  Alan C Sull; Laurel N Vuong; Lori Lyn Price; Vivek J Srinivasan; Iwona Gorczynska; James G Fujimoto; Joel S Schuman; Jay S Duker
Journal:  Retina       Date:  2010-02       Impact factor: 4.256

9.  Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema.

Authors:  Farzin Forooghian; Paul F Stetson; Scott A Meyer; Emily Y Chew; Wai T Wong; Catherine Cukras; Catherine B Meyerle; Frederick L Ferris
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

10.  South Asian diabetic macular oedema treated with ranibizumab (ADMOR)-real-life experience.

Authors:  F Ghanchi; C A Hazel
Journal:  Eye (Lond)       Date:  2015-10-23       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.